Vanguard Group’s DiaMedica Therapeutics DMAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.99M | Buy |
1,535,054
+183,587
| +14% | +$716K | ﹤0.01% | 3145 |
|
|
2025
Q1 | $5.12M | Buy |
1,351,467
+109,360
| +9% | +$414K | ﹤0.01% | 3161 |
|
|
2024
Q4 | $6.74M | Buy |
1,242,107
+193,078
| +18% | +$1.05M | ﹤0.01% | 3143 |
|
|
2024
Q3 | $4.4M | Buy |
1,049,029
+31,627
| +3% | +$133K | ﹤0.01% | 3314 |
|
|
2024
Q2 | $3M | Buy |
1,017,402
+3,880
| +0.4% | +$11.4K | ﹤0.01% | 3434 |
|
|
2024
Q1 | $2.81M | Buy |
1,013,522
+211,351
| +26% | +$585K | ﹤0.01% | 3488 |
|
|
2023
Q4 | $2.28M | Buy |
802,171
+13,382
| +2% | +$38K | ﹤0.01% | 3557 |
|
|
2023
Q3 | $2.04M | Buy |
788,789
+5,800
| +0.7% | +$15K | ﹤0.01% | 3573 |
|
|
2023
Q2 | $3.38M | Hold |
782,989
| – | – | ﹤0.01% | 3474 |
|
|
2023
Q1 | $1.2M | Hold |
782,989
| – | – | ﹤0.01% | 3862 |
|
|
2022
Q4 | $1.24M | Buy |
782,989
+349
| +0% | +$551 | ﹤0.01% | 3836 |
|
|
2022
Q3 | $971K | Hold |
782,640
| – | – | ﹤0.01% | 4010 |
|
|
2022
Q2 | $1.58M | Hold |
782,640
| – | – | ﹤0.01% | 3910 |
|
|
2022
Q1 | $1.96M | Sell |
782,640
-3,912
| -0.5% | -$9.78K | ﹤0.01% | 3967 |
|
|
2021
Q4 | $2.93M | Sell |
786,552
-984
| -0.1% | -$3.67K | ﹤0.01% | 3883 |
|
|
2021
Q3 | $3.16M | Buy |
787,536
+1,270
| +0.2% | +$5.09K | ﹤0.01% | 3893 |
|
|
2021
Q2 | $3.5M | Sell |
786,266
-60,047
| -7% | -$267K | ﹤0.01% | 3768 |
|
|
2021
Q1 | $7.74M | Buy |
846,313
+66,415
| +9% | +$608K | ﹤0.01% | 3299 |
|
|
2020
Q4 | $7.91M | Buy |
779,898
+438,054
| +128% | +$4.44M | ﹤0.01% | 3117 |
|
|
2020
Q3 | $1.45M | Buy |
341,844
+100,027
| +41% | +$424K | ﹤0.01% | 3577 |
|
|
2020
Q2 | $1.68M | Sell |
241,817
-123
| -0.1% | -$852 | ﹤0.01% | 3479 |
|
|
2020
Q1 | $677K | Buy |
241,940
+160,885
| +198% | +$450K | ﹤0.01% | 3603 |
|
|
2019
Q4 | $393K | Hold |
81,055
| – | – | ﹤0.01% | 3838 |
|
|
2019
Q3 | $166K | Buy |
81,055
+46,817
| +137% | +$95.9K | ﹤0.01% | 3979 |
|
|
2019
Q2 | $170K | Buy |
+34,238
| New | +$170K | ﹤0.01% | 4001 |
|